Pfizer Is First Company To Post Clinical Trial Payments
This article was originally published in The Pink Sheet Daily
Executive Summary
Under a corporate integrity agreement, the firm's disclosures of payments to healthcare professionals include expenditures on research.
You may also be interested in...
Regulatory And Policy News, In Brief
PhRMA Names Top Gov't Relations Exec
Regulatory And Policy News, In Brief
PhRMA Names Top Gov't Relations Exec
Off-Label Prosecution May Be Where FDA "Parks" Aggressive Enforcement Tools First
FDA appears likely to target flagrant off-label promotion in its first cases under new procedures for using the Park Doctrine and strict liability statutes to prosecute corporate executives and others.